A Phase 1, First-in-human Study of VX-433

Clinical trial NCT07584434 · RECRUITING

Trial details

NCT number: NCT07584434
Sponsor: Vertex Pharmaceuticals Incorporated
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Narcolepsy Type 1 (NT1)

Start date: 2026-05-21
Primary completion: 2027-03-05
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.